Wrap Text
Notification of transactions by persons discharging managerial responsibilities and persons closely associated
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(‘Mediclinic’, or the ‘Company’, or the ‘Group’)
15 December 2022
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
On 14 December 2022, Gert Hattingh, Chief Governance Officer of Mediclinic, and persons closely
associated with him (‘PCA’), Ghwarriebos Investments (Pty) Ltd, sold a total of 100 000 shares in the
Company as set out below.
The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse
Regulation.
1. Details of persons discharging managerial responsibilities (‘PDMR’) / persons closely
associated with them (‘PCA’)
a) Name Gert Hattingh
2. Reason for the notification
a) Position / status Group Chief Governance Officer – Mediclinic International plc
b) Initial notification / Initial notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Ordinary shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Sale of shares
transaction
c) Price(s) and
volume(s) Price(s) Volume(s)
ZAR 105.00 23 678
d) Aggregated
information
Aggregated volume 23 678
Price ZAR 105.00 per share
e) Date of the 14 December 2022
transaction
f) Place of the JSE
transaction
1. Details of persons discharging managerial responsibilities (‘PDMR’) / persons closely
associated with them (‘PCA’)
a) Name Ghwarriebos Investments (Pty) Ltd
2. Reason for the notification
a) Position / status PCA
b) Initial notification / Initial notification
amendment
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or
auction monitor
a) Name Mediclinic International plc
b) LEI 2138002S5BSBIZTD5I60
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each
type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
a) Description of the Ordinary shares
financial instrument
Identification Code GB00B8HX8Z88
b) Nature of the Sale of shares
transaction
c) Price(s) and
volume(s) Price(s) Volume(s)
ZAR 105.00 12 527
ZAR 105.00 44 228
ZAR 105.00 18 238
ZAR 105.01 1 329
d) Aggregated
information
Aggregated volume 76 322
Price ZAR 105.00 per share
e) Date of the 14 December 2022
transaction
f) Place of the JSE
transaction
ABOUT MEDICLINIC INTERNATIONAL PLC
Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with
divisions in Switzerland, Southern Africa (South Africa and Namibia) and the Middle East.
The Group’s core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in
such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by
patients, medical practitioners, funders and regulators of healthcare in each of its markets.
At 30 September 2022, Mediclinic comprised 74 hospitals, five subacute hospitals, three mental health facilities,
21 day case clinics and 23 outpatient clinics. Hirslanden operated 17 hospitals and five day case clinics in
Switzerland with around 1 900 inpatient beds; Mediclinic Southern Africa operations included 50 hospitals (three
of which in Namibia), five subacute hospitals, three mental health facilities and 14 day case clinics (four of which
operated by Intercare) across South Africa, and around 8 700 inpatient beds; and Mediclinic Middle East operated
seven hospitals, two day case clinics and 23 outpatient clinics with around 1 000 inpatient beds in the UAE. In
addition, under management contract Mediclinic Middle East will open a 200-bed hospital in the Kingdom of Saudi
Arabia in 2023.
The Company’s primary listing is on the London Stock Exchange (‘LSE’) in the United Kingdom, with secondary
listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.7% (2022: 29.9%) interest in Spire Healthcare Group plc, a leading private healthcare
group based in the United Kingdom and listed on the LSE.
CONTACT INFORMATION
Investor queries
James Arnold, Head of Investor Relations, Mediclinic International plc
+44 (0)20 3786 8181
ir@mediclinic.com
Media queries
FTI Consulting
Ben Atwell/Ciara Martin – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Ltd)
NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd
Date: 15-12-2022 04:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
